FACTORS AFFECTING CARDIOLIPIN ANTIBODY-ASSAYS - MODIFICATION WITH POLYETHYLENE-GLYCOL COMPOUND

Authors
Citation
Dc. Kilpatrick, FACTORS AFFECTING CARDIOLIPIN ANTIBODY-ASSAYS - MODIFICATION WITH POLYETHYLENE-GLYCOL COMPOUND, British Journal of Haematology, 100(1), 1998, pp. 52-57
Citations number
15
Categorie Soggetti
Hematology
ISSN journal
00071048
Volume
100
Issue
1
Year of publication
1998
Pages
52 - 57
Database
ISI
SICI code
0007-1048(1998)100:1<52:FACA-M>2.0.ZU;2-3
Abstract
Anti-cardiolipin antibody (aCL) measurement is only semi-reproducible, and current assays detect irrelevant as well as clinically significan t antibodies. Factors found to influence results included the source o f enzyme-linked immunoabsorbent assay (ELISA) plate, and its pretreatm ent with solvents; the nature of the blocking solution; and the compos ition of the diluent used for reagents. Fetal calf serum (FCS) in the diluent appeared to reduce non-specific (clinically irrelevant) bindin g and was not simply a source of beta(2)-glycoprotein-1 (beta(2)-GP1). A polyethylene glycol compound was found to be an effective blocking agent, and its use enhanced the discrimination between positive and ne gative samples. A high level of variation may be inherent in a aCL-ELI SA methodology, but the use of polyethylene glycol compound appeared t o be a helpful modification.